InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Meyenburg Jason Patrick, Chairman & CEO. Officer active across 2 companies, notably Gemini Therapeutics, Inc. /DE. Aggregated, 2 reports have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €204k. Activity tracked since 14 May 2021. The latest transaction was filed on 14 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
13,000 shares@ US$9.4561100.0% of flowCommon StockSEC:0000899243-21-019762
Ideal exit: 8 Feb 2022 (T+270)
13,000 shares@ US$9.4561100.0% of flowCommon StockSEC:0000899243-21-019762:0
Ideal exit: 8 Feb 2022 (T+270)
2 of 2 declarations
About Meyenburg Jason Patrick
Jason Patrick Meyenburg is President and CEO at Gemini Therapeutics, Inc. He is responsible for the strategic direction of the company, focusing on innovation in the field of genetic therapies. Jason Patrick Meyenburg is committed to promoting a corporate culture centered on excellence and accountability.
